Balversa
| Balversa | |
|---|---|
| Term | Balversa |
| Short definition | Balversa - (pronounced) (bal-VER-suh) drug used to treat adults with urothelial cancer (a type of bladder or urinary tract cancer) that is locally advanced or has spread and has certain mutations (changes) in the tumorFGFR3orFGFR2gene or a fusion gene involving these genes. It is used in patients whose cancer has gotten worse during or after treatment with at least one type of platinum chemotherapy. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Balversa - (pronounced) (bal-VER-suh) drug used to treat adults with urothelial cancer (a type of bladder or urinary tract cancer) that is locally advanced or has spread and has certain mutations (changes) in the tumorFGFR3orFGFR2gene or a fusion gene involving these genes. It is used in patients whose cancer has gotten worse during or after treatment with at least one type of platinum chemotherapy. It is also being studied in the treatment of other types of cancer. Balversa blocks FGFR and other proteins that can help prevent cancer cells from growing and kill them. It's a type of tyrosine kinase inhibitor. Also called erdafitinib
External links
- Medical encyclopedia article on Balversa
- Wikipedia's article - Balversa
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski